Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients

Name: Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients
License: Public Domain

Tanta University

ClinicalTrials.gov · Datasets · License: Public Domain

sodium-glucose transport protein two inhibitor (sglt2),metabolic deficits caused by antipsychotics

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 307435
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.